NewGenIvf (NIVF)

The company serves clients across markets including China and Hong Kong SAR, Thailand, Cambodia, the United States, and Kyrgyzstan. Its revenue profile is concentrated in IVF treatment services, and Kyrgyzstan represents its largest revenue-generating geography based on the company’s reported business mix. This gives NewGenIvf exposure to the cross-border fertility services market, where patients may seek treatment options outside their home country because of cost, availability, regulation, or specialist expertise.

NewGenIvf describes itself as a technology-forward and diversified group, with interests that extend beyond reproductive health into areas such as real estate development and digital asset innovation. For investors, however, the company’s near-term operating identity is shaped primarily by fertility treatment and referral services rather than by those broader initiatives.

As a small, multi-jurisdictional healthcare business, NewGenIvf operates in markets where medical regulation, patient trust, clinical standards, and local legal frameworks are central to the business model. Its Class A ordinary shares provide public-market exposure to a niche segment of healthcare demand tied to assisted reproduction, fertility tourism, and related care services.